Cleared Traditional

K193024 - Sensititre 20-24 hour Haemophilus influ...

K193024 is an FDA 510(k) clearance for Sensititre 20-24 hour Haemophilus influ..., manufactured by Thermo Fisher Scientific. The device is a Class 2 Microbiology device with product code JWY cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K193024 · Thermo Fisher Scientific · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
70d
Days
Class 2
Risk

K193024 is an FDA 510(k) clearance for the Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or .... Classified as Manual Antimicrobial Susceptibility Test Systems (product code JWY), Class II - Special Controls.

Submitted by Thermo Fisher Scientific (Oakwood Village, US). The FDA issued a Cleared decision on January 8, 2020 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Thermo Fisher Scientific devices

FDA 510(k) Submission Details - K193024

510(k) Number K193024 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 2019
Decision Date January 08, 2020
Days to Decision 70 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 102d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JWY Device Classification - Class 2, Special Controls

Product Code JWY Manual Antimicrobial Susceptibility Test Systems
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JWY Manual Antimicrobial Susceptibility Test Systems

All 391
Devices cleared under the same product code (JWY) and FDA review panel - the closest regulatory comparables to K193024.
MTS Lefamulin 0.016- 256 µg/mL
K200308 · Liofilchem S. R. 1. · Apr 2020
MTS Omadacycline 0.002 - 32 ug/mL
K200180 · Liofilchem S. R. L. · Mar 2020
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 µg/ml
K193538 · Thermo Fisher Scientific · Mar 2020
ETEST Delafloxacin (DFX) (0.002-32 µg/mL)
K192738 · Biomerieux S.A. · Nov 2019
MicroScan Dried Gram Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32ug/mL)
K192355 · Beckman Coulter, Inc. · Nov 2019
Sensititre 18-24 Hour MIC or Breakpoint Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/ml
K192729 · Thermo Fisher Scientific · Nov 2019